Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands

被引:41
作者
Burg, Lara [1 ]
Timmermans, Maite [2 ,3 ,4 ]
van der Aa, Maaike [2 ]
Boll, Dorry [5 ]
Rovers, Koen [6 ]
de Hingh, Ignace [6 ]
van Altena, Anne [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynecol, Geert Grootepl Zuid 10, NL-6525 GA Nijmegen, Netherlands
[2] Netherlands Comprehens Canc Org IKNL, Dept Res, Utrecht, Netherlands
[3] Maastricht Univ, Med Ctr, Dept Obstet & Gynecol, Maastricht, Netherlands
[4] GROW, Sch Oncol & Dev Biol, Maastricht, Netherlands
[5] Catharina Hosp, Dept Obstet & Gynecol, Eindhoven, Netherlands
[6] Catharina Canc Hosp, Dept Surg Oncol, Eindhoven, Netherlands
关键词
Peritoneal Neoplasms; Ovarian Neoplasms; Endometrial Neoplasms; Uterine Cervical Neoplasms; Incidence; Epidemiology; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; QUALITY-OF-LIFE; CYTOREDUCTIVE SURGERY; OVARIAN-CANCER; ENDOMETRIAL CANCER; CLEAR-CELL; PACLITAXEL; CARCINOMA; CISPLATIN; SURVIVAL;
D O I
10.3802/jgo.2020.31.e58
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Peritoneal metastases (PM) are a challenge in gynecological cancers, but its appearance has never been described in a population-based study. Therefore, we describe the incidence of PM and identify predictors that increase the probability of peritoneal spread. Methods: All ovarian, endometrial and cervical cancer patients diagnosed in the Netherlands between 1989 and 2015 were identified from the Netherlands Cancer Registry and stratified for PM. Crude and age-adjusted incidence over time was calculated. Independent predictors for PM were identified using uni- and multivariable analyses. Results: The 94,981 patients were diagnosed with ovarian, endometrial or cervical cancer and respectively 61%, 2% and 1% presented with PM. Predictors for PM in ovarian cancer were: age between 50 and 74 years (odds ratio [OR]=1.19; 95% confidence interval [CI]=1.08-1.32), other distant metastases (OR=1.25; 95% CI=1.10-1.41), poor differentiation grade (OR=2.00; 95% CI=1.73-2.32) and serous histology. Predictors in endometrial cancer were lymph node metastases (OR=2.32; 95% CI=1.65-3.26), other distant metastases (OR=1.38; 95% CI=1.08-1.77), high-grade tumors (OR=1.95; 95% CI=1.38-2.76) and clear cell (OR=1.49; 95% CI=1.04-2.13) or serous histology (OR=2.71; 95% CI=2.15-3.42). In cervical cancer, the risk is higher in adenocarcinoma than in squamous cell carcinoma (OR=4.92; 95% CI=3.11-7.79). Conclusion: PM are frequently seen in patients with ovarian cancer. In endometrial and cervical cancer PM are rare. Histological subtype was the strongest predictive factor for PM in all 3 cancers. Better understanding of predictive factors for PM and thus the biological behavior is of paramount importance.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 42 条
  • [1] Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer
    Alberts, DS
    Liu, PY
    Hannigan, EV
    OToole, R
    Williams, SD
    Young, JA
    Franklin, EW
    ClarkePearson, DL
    Malviya, VK
    DuBeshter, B
    Adelson, MD
    Hoskins, WJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) : 1950 - 1955
  • [2] Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experience
    Alexandre, J.
    Ray-Coquard, I.
    Selle, F.
    Floquet, A.
    Cottu, P.
    Weber, B.
    Falandry, C.
    Lebrun, D.
    Pujade-Lauraine, E.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (12) : 2377 - 2381
  • [3] [Anonymous], NEW FIGO OV CANC STA
  • [4] Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer
    Ansaloni, L.
    Coccolini, F.
    Morosi, L.
    Ballerini, A.
    Ceresoli, M.
    Grosso, G.
    Bertoli, P.
    Busci, L. M.
    Lotti, M.
    Cambria, F.
    Pisano, M.
    Rossetti, D.
    Frigerio, L.
    D'Incalci, M.
    Zucchetti, M.
    [J]. BRITISH JOURNAL OF CANCER, 2015, 112 (02) : 306 - 312
  • [5] Evaluation of Extensive Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Epithelial Ovarian Cancer
    Ansaloni, Luca
    Agnoletti, Vanni
    Amadori, Andrea
    Catena, Fausto
    Cavaliere, Davide
    Coccolini, Federico
    De Iaco, Pierandrea
    Di Battista, Monica
    Framarini, Massimo
    Gazzotti, Filippo
    Ghermandi, Claudio
    Kopf, Barbara
    Saponara, Maristella
    Tauceri, Francesca
    Vallicelli, Carlo
    Verdecchia, Giorgio Maria
    Pinna, Antonio Daniele
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (05) : 778 - 785
  • [6] Intraperitoneal cisplatin and paclitaxel in ovarian cancer
    Armstrong, DK
    Bundy, B
    Wenzel, L
    Huang, HQ
    Baergen, R
    Lele, S
    Copeland, LJ
    Walker, JL
    Burger, RA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) : 34 - 43
  • [7] Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer
    Bakrin, N.
    Classe, J. M.
    Pomel, C.
    Gouy, S.
    Chene, G.
    Glehen, O.
    [J]. JOURNAL OF VISCERAL SURGERY, 2014, 151 (05) : 347 - 353
  • [8] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Persistent and Recurrent Advanced Ovarian Carcinoma: A Multicenter, Prospective Study of 246 Patients
    Bakrin, N.
    Cotte, E.
    Golfier, F.
    Gilly, F. N.
    Freyer, G.
    Helm, W.
    Glehen, O.
    Bereder, J. M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (13) : 4052 - 4058
  • [9] Peritoneal carcinomatosis after laparoscopic radical hysterectomy for early-stage cervical adenocarcinoma
    Belval, Camille Challan
    Barranger, Emmanuel
    Dubernard, Gil
    Touboul, Emmanuel
    Houry, Sidney
    Darai, Emile
    [J]. GYNECOLOGIC ONCOLOGY, 2006, 102 (03) : 580 - 582
  • [10] Management of women with uterine papillary serous cancer: A Society of Gynecologic Oncology (SGO) review
    Boruta, David M., II
    Gehrig, Paola A.
    Fader, Amanda Nickles
    Olawaiye, Alexander B.
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 115 (01) : 142 - 153